Casi Pharmaceuticals Inc's ROI from its fourth quarter of 2025 to the fourth quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Casi Pharmaceuticals Inc's ROI in the fourth quarter of 2025?
Due to the stockholders deficit and subsequent negative measured investments, it was not possible to calculate Casi Pharmaceuticals Inc 's return on investment (ROI) in its fourth quarter of 2025

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Dec 31 2025) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Dec 31 2024) IV. Quarter
Y / Y Investment Change TTM	-	-	-	-85.23 %	-70.27 %
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	-26	-24	-24	-24	18
Return On Investment (TTM)	-	-	-	-	-224.89 %
CASIF's Overall Ranking	#	#	#	#	#
Seq. Investment Change TTM	-	-	-	-59.06 %	-37.03 %
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	-48	-39	-39	-39	-39

CASIF Company Profile >> Back to CASIF Roi Comparisons >> See Annual CASIF Return On Investment

Return On Investment CASIF's Ranking
Within:	No.
Industry	#
Sector	#
Overall	#

Return On Investment Statistics
High	Average	Low
0 %	0 %	0 %

Financial Statements
Casi Pharmaceuticals Inc's IV. Quarter Investments	$ -26 Millions	CASIF's Balance sheet
Casi Pharmaceuticals Inc's IV. Quarter Income	$ -48 Millions	Quarterly CASIF's Income Statement
CASIF's Income by Division		See CASIF's Income by Division

CASIF Annual Return On Investment	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022
Total Investments in Millions	-23	18	59	82	0
Y / Y Investment Growth	-	-69.34 %	-27.6 %	-	-
Net Income in Millions	-48	-39	-26	-40	0
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	-	-216.19 %	-44.34 %	-49.22 %	-

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
CASIF's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for CASIF's Competitors
Subscribers only: Roi for Casi Pharmaceuticals Inc's Suppliers
Subscribers only: Return On Investment for CASIF's Customers

Other Ratios
CASIF's Roa	CASIF's Inventory Turnover Ratio	CASIF's Growth Rates	CASIF's Dividend Statistics
	CASIF's Profitability Ratios	CASIF's Asset Turnover Ratio	CASIF's Dividend Growth
CASIF's Roe	CASIF's Valuation Ratios	CASIF's Financial Strength Ratios	CASIF's Dividend Payout Ratio

Companies with similar Return On Investment at Dec 31 2025, within Healthcare Sector	ROI
Glucotrack Inc	372.04 %
Elutia Inc	358.27 %
Oncotelic Therapeutics Inc	252.91 %
Atara Biotherapeutics Inc	242.55 %
Traws Pharma inc	234.73 %
Scisparc Ltd	234.01 %
Petros Pharmaceuticals inc	233.39 %
Omada Health Inc	200.69 %
Interpace Biosciences Inc	198.59 %
Rigel Pharmaceuticals Inc	185.38 %
Icecure Medical Ltd	166.12 %
Silexion Therapeutics Corp	142.64 %
Heartflow Inc	142.09 %
Capforce Inc	140.91 %
Check Cap Ltd	120.45 %
Coherus Oncology inc	119.44 %
Kyntra Bio Inc	118.89 %
Lifemd Inc	105.75 %
Biocryst Pharmaceuticals Inc	88.36 %
Advanced Biomed Inc.	84.64 %
Earth Science Tech Inc	78.43 %
Exelixis Inc	71.31 %
Entera Bio Ltd	63.91 %
Tg Therapeutics Inc	63.77 %
Aurinia Pharmaceuticals Inc	56.37 %
Pulmatrix Inc	53.09 %
Novavax inc	51.88 %
Gsk Plc	51.22 %
Q32 Bio Inc	50.33 %
Idexx Laboratories Inc	48.69 %

Date modified: 2026-09-08T15:11:41+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.